Page last updated: 31-AUG-2010
Skin Cancers
Data analyses and reports
-
-
A
summary table of the main statistics for malignant melanoma of the skin.
-
Cancer in Scotland Summary 
[264KB] is an overview of cancer in Scotland focusing on incidence, mortality and survival for the main cancer sites.
-
-
-
Cancer Research UK factsheets provide detailed analyses and interpretation of cancer data.
-
Malignant melanoma of the skin: ICD-10 C43
| Incidence: |
Annual incidence [1705KB] (1985 onwards) by age, sex, network and health board |
|
Five year summary of incidence[281KB] by age, sex, network and health board |
| Mortality: |
Annual mortality[1338KB] (1985 onwards) by age, sex, network and health board |
|
Five year summary of mortality[229KB] by age, sex, network and health board |
| Survival: |
Survival[33KB] (by age and sex) at 1, 3, 5 & 10 years after diagnosis (1983 onwards) |
|
Survival summary [450KB] and interpretation at 1 & 5 years after diagnosis (1983 onwards) |
| Prevalence: |
Cancer prevalence[61KB] |
| Lifetime risk: |
Lifetime risk[45KB] of cancer by age and sex |
| Deprivation: |
Incidence and mortality by deprivation category [34KB] |
Non-melanoma skin cancer: ICD-10 C44
Basal cell carcinoma of the skin: ICD-10 C44 M-8090-8098
Squamous cell carcinoma of the skin: ICD-10 C44 M-8050-8078, 8083-8084
Summary statistics for malignant melanoma of the skin
| Scotland |
Males |
Females |
| Rank - incidence |
8 |
4 |
| Rank - mortality |
16 |
18 |
| Percentage frequency of all cancers |
3.4% |
4.4% |
| Number of new cases diagnosed in 2007 |
453 |
632 |
| Number of deaths recorded in 2008 |
93 |
78 |
| Change in incidence from 1997 to 2007 |
+57.1% |
+51.5% |
| Change in mortality from 1998 to 2008 |
+30.1% |
+4.1% |
| 1 year relative survival for patients diagnosed between 2003 and 2007 |
96.0% |
98.9% |
| 5 year relative survival for patients diagnosed between 2003 and 2007 |
87.8% |
95.5% |
Notes:
1. Survival figures are not age standardised.
2. Change in incidence and mortality is estimated by Poisson regression.
3. Non-melanoma skin cancer is often excluded from comparative analyses of cancer data, both because of concerns about the completeness of registration and a perception that cancers of this kind are rarely life threatening. Most non-melanoma skin cancers are detected early and can be treated on an outpatient basis (the lack of a discharge record for such patients is one of the reasons why registration of new cases is less complete than for other cancers, most of which involve hospitalisation). Nevertheless, case ascertainment is believed to be sufficient to justify publication of data on non-melanoma skin cancer in their own right. However, it should be noted that these data underestimate the true risk of non-melanoma skin cancer, not least because only the first basal cell carcinoma per patient is registered. It should be also noted that incidence data underestimate workload because, by definition, they only include new independent primary cancers, and therefore exclude re-biopsies, re-excisions and recurrent disease. More detailed discussion of these issues can be found in this publication [145KB].
For queries or to give feedback: Cancer Stats
Printer friendly version
